G1 Therapeutics Announces Inducement Grants Under Nasdaq
RESEARCH TRIANGLE PARK, N.C., Feb. 01, 2022 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq: GTHX), a commercial-stage oncology company, today...
Therapeutics Inc Corporate Communications Research Triangle Park Sales Force Inducement Plan Equity Incentive Plan Force Inducement Equity Incentive Plan
Source: globenewswire.com